Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Laboratories, Diagenode Partner to Offer Single Cell ATAC-Seq Services

NEW YORK – Epigenetics research and sample preparation service provider Diagenode announced Tuesday that it has partnered with Bio-Rad Laboratories to offer its single-cell transposase accessible chromatin by sequencing (ATAC-seq) services on Bio-Rad's droplet digital technology. Terms of the deal were not disclosed.

The Diagenode scATAC-Seq services will utilize Bio-Rad's ddSEQ Single-Cell Isolator to encapsulate thousands of cell nuclei or whole cells into nanoliter-sized droplets and offer robust precision and quantification of data, the firm said in a statement.

"By working together to combine our expertise, we look forward to accelerating epigenetics and gene regulation research at the single-cell level," said Kris Simonyi, global marketing manager of Bio-Rad's Digital Biology Group.

For epigenetics studies, Diagenode offers shearing and automation instruments, reagent kits, antibodies to streamline DNA methylation, noncoding RNA-seq, ChIP, and ChIP-seq workflows. The company's newest products include a full automation system, a Reduced Representation Bisulfite Sequencing (RRBS) Kit providing eight times more coverage than standard technologies, and ChIPmentation and ChIP-seq kits for only 10,000 cells. Bio-Rad also recently launched a single-cell chromatin profiling assay that is based on ATAC-seq technology.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.